This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

28 Jan 2011

Takeda Completes API Manufacturing Facility

Takeda Pharmaceutical has completed construction of its new API manufacturing facility for investigational antibody within the premises of Hikari Plant.

Takeda Pharmaceutical Company has completed its new API manufacturing facility for investigational antibodies that was started in March 2010. The total construction cost is put at ¥5.5bn, and the total floor area is approximately 4,400m2.


Constructed within the premise of the Hikari plant, located in Hikari City, Yamaguchi Prefecture in Japan, this is Takeda's first manufacturing facility specialised in antibody drugs. Its aims are the research and development of manufacturing processes with high efficiency and cost competitiveness, and the production of investigational new drug substances.


Takeda has established a system aimed at facilitating rapid commer

Related News